Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Alexandre IatMichael LoschiSami BenachourAnne CallejaEdmond ChicheIsabelle SudakaDanièle AquaronneCorinne FerreroLaurène FenwarthAlice MarceauElise FournierBerengere Dadone-MontaudieThomas CluzeauPublished in: Cancer medicine (2024)
Using Akaike's information criteria (AIC) to compare all five classifiers, ELN 2022 is the best classifier into younger and older patients and for prognosis.